Skip to content
Technology Opportunities & Ventures
While focus is on header menu items,
press the down arrow to open sub-menu.

For Innovators

Getting your innovations out into the world and to the people that need them.

In This Section

‹ Home › Startups › Our Startup Portfolio › Repare Therapeutics

Startups

Repare Therapeutics

Repare Therapeutics

2017
Active

Principal Investigators: Agnel Sfeir, PhD

Repare Therapeutics is a prominent precision oncology company in the clinical stage, powered by their exclusive synthetic lethality method of discovering and developing new therapeutics. The company utilizes its SNIPRx® platform, which is enabled by CRISPR and genome-wide analysis, to systematically discover and develop cancer therapies with a high degree of precision, targeting genomic instability and DNA damage repair specifically.